2 results
Approved WMOCompleted
Primary objective: To demonstrate a clinically significant improvement in morning FEV1 in moderate to severe allergic asthmatics inadequately controlled by ICS therapy treated with QAW039 for 12 weeks compared to placebo.Secondary objectives:…
Approved WMOCompleted
1. To adapt and optimize the MR protocol to enable multi-parametric dynamic acquisitions during 1 hour of mild-cold exposure.2. To investigate tissue dynamics of metabolic activity of the hypothalamus, BAT, and skeletal muscles, measured by dynamic…